首页> 中文期刊> 《世界核心医学期刊文摘:皮肤病学分册》 >局部外用甲基氨基酮戊酸(Metvix~)-PDT治疗颜面和头皮光化性角化症:两种给药法的随机多中心比较研究

局部外用甲基氨基酮戊酸(Metvix~)-PDT治疗颜面和头皮光化性角化症:两种给药法的随机多中心比较研究

         

摘要

cqvip:Photodynamic therapy (PDT) with topical methyl aminolevulinate (MAL) administered in two treatment sessions separated by 1 week is an effective treatment for actinic keratoses. This open prospective study compared the efficacy and safety of MAL- PDT given as a single treatment with two treatments of MAL- PDT 1 week apart. Two hundred and eleven patients with 413 thin to moderately thick actinic keratoses were randomized to either a single treatment with PDT using topical MAL (regimen I; n=105) or two treatments 1 week apart (regimen II; n=106). Each treatment involved surface debridement, application of Metvix(r) cream (160 mg/g) for 3 h, followed by illumination with red light using a light- emitting diode system (peak wave length 634± 3 nm, light dose 37 J/cm2). Thirtyseven lesions (19% ) with a non- complete response 3 months after a single treatment were re- treated. All patients were followed up 3 months after the last treatment. A total of 400 lesions, 198 initially treated once and 202 treated twice, were evaluable. Complete response rate for thin lesions after a single treatment was 93% (95% CI=87- 97% ), which was similar to 89% (82- 96% ) after repeated treatment. Response rates were lower after single treatment of thicker lesions (70% (60- 78% )- vs 84% (77- 91% )), but improved after repeated treatment (88% (82- 94% )). The conclusion of this study is that single treatment with topical MAL- PDT is effective for thin actinic keratosis lesions; however, repeated treatment is recommended for thicker or non- responding lesions.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号